← Leaderboards
Simon Eschweiler
La Jolla Institute For Immunology
$1,061,759
Attributed
$1,061,759
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $418.6K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$1,061,759 · 1
By mechanism
R37$1,061,759 · 1
Top collaborators
No co-investigators on record.
Most similar at La Jolla Institute For Immunology
Same institution · by research overlap
- Pandurangan Vijayanand$21,136,772
- Alessandro Sette$107,498,738
- Gregory Seumois$7,311,002
- Michael Croft$34,527,225
- Christopher A Benedict$10,015,835
Others in their field
Other Rising Stars on “Affect”
- Daniel Hunter Reirden · Westat, Inc.$15,038,020
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Xuping Xie · University Of Texas Med Br Galveston$13,737,799
- Brian Todd Schaneberg · Illinois Institute Of Technology$13,469,813
- Benjamin M Greenberg · Ut Southwestern Medical Center$11,474,975
- Eric Anderson · Columbia University Health Sciences$11,474,975
Research focus
AffectAntibodiesAnti-Ctla4AntigensAnti-Pd1 TherapyAntitumor EffectAntitumor ResponseAtac-SeqAutomobile DrivingCancer ImmunotherapyCancer TypeCd8-Positive T-LymphocytesCellsCell TypeCellular ImmunotherapyCellular TargetingChromatin ImmunoprecipitationCohortColitisColonCombined Modality TherapyCtla4 GeneDna BindingAdoptive Transfer
Grant awards (4)
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy$412,739
R37 · FY2025 · CA · contact PI
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy$230,407
R37 · FY2024 · CA · contact PI
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy$316,163
R37 · FY2023 · CA · contact PI
Evaluation of T follicular regulatory cells as novel cellular targets of cancer immunotherapy$102,450
R37 · FY2023 · CA · contact PI